Skip to content

SIGA Technologies SIGA Free cash flow

Free cash flow at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
-$36.2M-145%
Opko Health logo
Opko HealthOPK
-$21.14M+44.0%
Merck & Co. logo
Merck & Co.MRK
$2.93B+150%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$60.94M-146%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$26.47M-11.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$62.75M+7.3%

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's free cash flow?
SIGA Technologies (SIGA) reported free cash flow of -$8.66M in Q1 2026.
How has SIGA Technologies's free cash flow changed year-over-year?
SIGA Technologies's free cash flow decreased by 223.1% year-over-year, from $7.04M to -$8.66M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.